nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—Gallbladder disorder—Varenicline—nicotine dependence	0.051	0.0586	CcSEcCtD
Medroxyprogesterone Acetate—Facial paralysis—Varenicline—nicotine dependence	0.0263	0.0302	CcSEcCtD
Medroxyprogesterone Acetate—Varicose vein—Varenicline—nicotine dependence	0.0225	0.0258	CcSEcCtD
Medroxyprogesterone Acetate—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0204	0.0234	CcSEcCtD
Medroxyprogesterone Acetate—Rash generalised—Varenicline—nicotine dependence	0.0197	0.0226	CcSEcCtD
Medroxyprogesterone Acetate—Hoarseness—Varenicline—nicotine dependence	0.019	0.0219	CcSEcCtD
Medroxyprogesterone Acetate—Pancreatitis acute—Varenicline—nicotine dependence	0.0181	0.0208	CcSEcCtD
Medroxyprogesterone Acetate—Transient ischaemic attack—Varenicline—nicotine dependence	0.0166	0.0191	CcSEcCtD
Medroxyprogesterone Acetate—Balance disorder—Varenicline—nicotine dependence	0.0153	0.0176	CcSEcCtD
Medroxyprogesterone Acetate—Osteoporosis—Varenicline—nicotine dependence	0.0149	0.0172	CcSEcCtD
Medroxyprogesterone Acetate—Vaginal discharge—Varenicline—nicotine dependence	0.0138	0.0158	CcSEcCtD
Medroxyprogesterone Acetate—Libido increased—Varenicline—nicotine dependence	0.0138	0.0158	CcSEcCtD
Medroxyprogesterone Acetate—Cyst—Varenicline—nicotine dependence	0.0125	0.0144	CcSEcCtD
Medroxyprogesterone Acetate—Paranoia—Varenicline—nicotine dependence	0.0123	0.0141	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—brain—nicotine dependence	0.0119	0.152	CbGeAlD
Medroxyprogesterone Acetate—Thrombosis—Varenicline—nicotine dependence	0.0118	0.0136	CcSEcCtD
Medroxyprogesterone Acetate—Menorrhagia—Varenicline—nicotine dependence	0.0113	0.013	CcSEcCtD
Medroxyprogesterone Acetate—Nephrolithiasis—Varenicline—nicotine dependence	0.0104	0.012	CcSEcCtD
Medroxyprogesterone Acetate—Glycosuria—Varenicline—nicotine dependence	0.0103	0.0119	CcSEcCtD
Medroxyprogesterone Acetate—Dysphonia—Varenicline—nicotine dependence	0.0102	0.0117	CcSEcCtD
Medroxyprogesterone Acetate—Endocrine disorder—Varenicline—nicotine dependence	0.0101	0.0116	CcSEcCtD
Medroxyprogesterone Acetate—Acne—Varenicline—nicotine dependence	0.00995	0.0114	CcSEcCtD
Medroxyprogesterone Acetate—Tenderness—Varenicline—nicotine dependence	0.0096	0.011	CcSEcCtD
Medroxyprogesterone Acetate—Leukocytosis—Varenicline—nicotine dependence	0.00891	0.0102	CcSEcCtD
Medroxyprogesterone Acetate—Dysarthria—Varenicline—nicotine dependence	0.00885	0.0102	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal pain—Varenicline—nicotine dependence	0.00847	0.00974	CcSEcCtD
Medroxyprogesterone Acetate—Blood pressure increased—Varenicline—nicotine dependence	0.00837	0.00962	CcSEcCtD
Medroxyprogesterone Acetate—Pulmonary embolism—Varenicline—nicotine dependence	0.00837	0.00962	CcSEcCtD
Medroxyprogesterone Acetate—Hyperkalaemia—Varenicline—nicotine dependence	0.00823	0.00945	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—midbrain—nicotine dependence	0.00799	0.102	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cardiovascular system—nicotine dependence	0.00769	0.0983	CbGeAlD
Medroxyprogesterone Acetate—Mouth ulceration—Varenicline—nicotine dependence	0.00757	0.0087	CcSEcCtD
Medroxyprogesterone Acetate—Euphoric mood—Varenicline—nicotine dependence	0.00719	0.00826	CcSEcCtD
Medroxyprogesterone Acetate—Diabetes mellitus—Varenicline—nicotine dependence	0.00699	0.00803	CcSEcCtD
Medroxyprogesterone Acetate—PGR—cardiovascular system—nicotine dependence	0.00693	0.0886	CbGeAlD
Medroxyprogesterone Acetate—Libido decreased—Varenicline—nicotine dependence	0.00655	0.00753	CcSEcCtD
Medroxyprogesterone Acetate—Hot flush—Varenicline—nicotine dependence	0.0065	0.00746	CcSEcCtD
Medroxyprogesterone Acetate—Increased appetite—Varenicline—nicotine dependence	0.00647	0.00743	CcSEcCtD
Medroxyprogesterone Acetate—Amnesia—Varenicline—nicotine dependence	0.00647	0.00743	CcSEcCtD
Medroxyprogesterone Acetate—Menopausal symptoms—Varenicline—nicotine dependence	0.00644	0.0074	CcSEcCtD
Medroxyprogesterone Acetate—Visual disturbance—Varenicline—nicotine dependence	0.00641	0.00737	CcSEcCtD
Medroxyprogesterone Acetate—Thirst—Varenicline—nicotine dependence	0.00639	0.00734	CcSEcCtD
Medroxyprogesterone Acetate—Hypoglycaemia—Varenicline—nicotine dependence	0.00623	0.00715	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Retinoid metabolism and transport—AKR1B10—nicotine dependence	0.0062	0.121	CbGpPWpGaD
Medroxyprogesterone Acetate—Cerebrovascular accident—Varenicline—nicotine dependence	0.0062	0.00712	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Varenicline—nicotine dependence	0.00608	0.00698	CcSEcCtD
Medroxyprogesterone Acetate—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00603	0.00693	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Varenicline—nicotine dependence	0.00598	0.00687	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Varenicline—nicotine dependence	0.00598	0.00687	CcSEcCtD
Medroxyprogesterone Acetate—Psychotic disorder—Varenicline—nicotine dependence	0.00594	0.00682	CcSEcCtD
Medroxyprogesterone Acetate—Irritability—Varenicline—nicotine dependence	0.0058	0.00666	CcSEcCtD
Medroxyprogesterone Acetate—Urinary retention—Varenicline—nicotine dependence	0.00578	0.00664	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Varenicline—nicotine dependence	0.00576	0.00661	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Varenicline—nicotine dependence	0.00557	0.0064	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Varenicline—nicotine dependence	0.00553	0.00635	CcSEcCtD
Medroxyprogesterone Acetate—AR—cardiovascular system—nicotine dependence	0.00552	0.0706	CbGeAlD
Medroxyprogesterone Acetate—Breast disorder—Varenicline—nicotine dependence	0.00549	0.00631	CcSEcCtD
Medroxyprogesterone Acetate—Cramp muscle—Varenicline—nicotine dependence	0.00547	0.00629	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Varenicline—nicotine dependence	0.00544	0.00624	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—cardiovascular system—nicotine dependence	0.00542	0.0693	CbGeAlD
Medroxyprogesterone Acetate—Abdominal distension—Varenicline—nicotine dependence	0.00529	0.00607	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Varenicline—nicotine dependence	0.00525	0.00603	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Varenicline—nicotine dependence	0.00525	0.00603	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Varenicline—nicotine dependence	0.00505	0.0058	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Varenicline—nicotine dependence	0.00504	0.00578	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—brain—nicotine dependence	0.00502	0.0642	CbGeAlD
Medroxyprogesterone Acetate—Pollakiuria—Varenicline—nicotine dependence	0.00485	0.00557	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Varenicline—nicotine dependence	0.00478	0.00549	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Varenicline—nicotine dependence	0.00474	0.00544	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Varenicline—nicotine dependence	0.00468	0.00538	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Varenicline—nicotine dependence	0.00468	0.00538	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Varenicline—nicotine dependence	0.00467	0.00536	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00465	0.0907	CbGpPWpGaD
Medroxyprogesterone Acetate—Acute coronary syndrome—Varenicline—nicotine dependence	0.00462	0.0053	CcSEcCtD
Medroxyprogesterone Acetate—Myocardial infarction—Varenicline—nicotine dependence	0.00459	0.00527	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Varenicline—nicotine dependence	0.00457	0.00524	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Varenicline—nicotine dependence	0.00443	0.00509	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Varenicline—nicotine dependence	0.00442	0.00507	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Varenicline—nicotine dependence	0.00439	0.00505	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Varenicline—nicotine dependence	0.00428	0.00492	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Varenicline—nicotine dependence	0.00415	0.00477	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Varenicline—nicotine dependence	0.00414	0.00476	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Varenicline—nicotine dependence	0.00413	0.00475	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Varenicline—nicotine dependence	0.00412	0.00473	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Varenicline—nicotine dependence	0.00405	0.00465	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—cardiovascular system—nicotine dependence	0.004	0.0511	CbGeAlD
Medroxyprogesterone Acetate—Erythema multiforme—Varenicline—nicotine dependence	0.00398	0.00457	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—cardiovascular system—nicotine dependence	0.00396	0.0507	CbGeAlD
Medroxyprogesterone Acetate—Eye disorder—Varenicline—nicotine dependence	0.00393	0.00451	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Varenicline—nicotine dependence	0.00392	0.0045	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Varenicline—nicotine dependence	0.0039	0.00448	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Varenicline—nicotine dependence	0.00381	0.00438	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Varenicline—nicotine dependence	0.0038	0.00436	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Varenicline—nicotine dependence	0.00379	0.00435	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00378	0.0738	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—brain—nicotine dependence	0.00377	0.0482	CbGeAlD
Medroxyprogesterone Acetate—Chills—Varenicline—nicotine dependence	0.00377	0.00433	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Varenicline—nicotine dependence	0.00368	0.00423	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Varenicline—nicotine dependence	0.00366	0.0042	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Varenicline—nicotine dependence	0.00366	0.0042	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Varenicline—nicotine dependence	0.00361	0.00414	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Varenicline—nicotine dependence	0.00358	0.00412	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Varenicline—nicotine dependence	0.00354	0.00407	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Varenicline—nicotine dependence	0.00352	0.00404	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Varenicline—nicotine dependence	0.00343	0.00394	CcSEcCtD
Medroxyprogesterone Acetate—PGR—brain—nicotine dependence	0.0034	0.0435	CbGeAlD
Medroxyprogesterone Acetate—Ill-defined disorder—Varenicline—nicotine dependence	0.0034	0.0039	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Varenicline—nicotine dependence	0.00338	0.00389	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Varenicline—nicotine dependence	0.00336	0.00386	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Varenicline—nicotine dependence	0.00334	0.00384	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Varenicline—nicotine dependence	0.0033	0.00379	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Varenicline—nicotine dependence	0.00329	0.00378	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Varenicline—nicotine dependence	0.00328	0.00377	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Varenicline—nicotine dependence	0.00323	0.00372	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Varenicline—nicotine dependence	0.00322	0.0037	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Varenicline—nicotine dependence	0.00317	0.00364	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Diseases associated with visual transduction—AKR1B10—nicotine dependence	0.00317	0.0618	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—midbrain—nicotine dependence	0.00312	0.0399	CbGeAlD
Medroxyprogesterone Acetate—Myalgia—Varenicline—nicotine dependence	0.00312	0.00358	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Varenicline—nicotine dependence	0.00312	0.00358	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Varenicline—nicotine dependence	0.00312	0.00358	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Varenicline—nicotine dependence	0.00311	0.00357	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00309	0.00355	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Varenicline—nicotine dependence	0.00308	0.00354	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Varenicline—nicotine dependence	0.00305	0.0035	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Varenicline—nicotine dependence	0.00299	0.00343	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Varenicline—nicotine dependence	0.00297	0.00341	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Varenicline—nicotine dependence	0.00294	0.00338	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Varenicline—nicotine dependence	0.00293	0.00337	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Varenicline—nicotine dependence	0.00292	0.00336	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Varenicline—nicotine dependence	0.00292	0.00335	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Varenicline—nicotine dependence	0.0029	0.00333	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Varenicline—nicotine dependence	0.00289	0.00332	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00288	0.0562	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Varenicline—nicotine dependence	0.00285	0.00327	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Varenicline—nicotine dependence	0.00279	0.00321	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00272	0.00313	CcSEcCtD
Medroxyprogesterone Acetate—AR—brain—nicotine dependence	0.00271	0.0346	CbGeAlD
Medroxyprogesterone Acetate—Insomnia—Varenicline—nicotine dependence	0.0027	0.0031	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Varenicline—nicotine dependence	0.00266	0.00306	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—brain—nicotine dependence	0.00266	0.034	CbGeAlD
Medroxyprogesterone Acetate—Somnolence—Varenicline—nicotine dependence	0.00266	0.00305	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Varenicline—nicotine dependence	0.00263	0.00302	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Varenicline—nicotine dependence	0.0026	0.00298	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00258	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Varenicline—nicotine dependence	0.00258	0.00296	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Varenicline—nicotine dependence	0.00255	0.00293	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Varenicline—nicotine dependence	0.00246	0.00283	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Varenicline—nicotine dependence	0.00244	0.00281	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Varenicline—nicotine dependence	0.00237	0.00273	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Varenicline—nicotine dependence	0.00236	0.00271	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Varenicline—nicotine dependence	0.00236	0.00271	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00234	0.0457	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Varenicline—nicotine dependence	0.0022	0.00253	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—brain—nicotine dependence	0.00219	0.028	CbGeAlD
Medroxyprogesterone Acetate—Asthenia—Varenicline—nicotine dependence	0.00214	0.00246	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Varenicline—nicotine dependence	0.00211	0.00243	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Varenicline—nicotine dependence	0.00204	0.00235	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Varenicline—nicotine dependence	0.00198	0.00227	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—brain—nicotine dependence	0.00196	0.0251	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00194	0.0379	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Varenicline—nicotine dependence	0.0019	0.00218	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Varenicline—nicotine dependence	0.00188	0.00216	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Varenicline—nicotine dependence	0.00188	0.00216	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Varenicline—nicotine dependence	0.00187	0.00215	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00181	0.0353	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Varenicline—nicotine dependence	0.00177	0.00204	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00155	0.0302	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0012	0.0233	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00118	0.023	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00114	0.0223	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000973	0.019	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000969	0.0189	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00096	0.0187	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000866	0.0169	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000789	0.0154	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000761	0.0149	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000691	0.0135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000642	0.0125	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP2A7—nicotine dependence	0.000634	0.0124	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000633	0.0124	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000578	0.0113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000546	0.0107	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000524	0.0102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00052	0.0102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000515	0.01	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000508	0.00991	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—CCAR1—nicotine dependence	0.000493	0.00962	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000445	0.00868	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000419	0.00818	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000413	0.00807	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TAS2R16—nicotine dependence	0.000406	0.00793	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKR1B10—nicotine dependence	0.000402	0.00785	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—CCAR1—nicotine dependence	0.000376	0.00733	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TAS2R16—nicotine dependence	0.000321	0.00626	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGD1—nicotine dependence	0.000319	0.00622	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP2A7—nicotine dependence	0.000313	0.00611	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000293	0.00572	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—CCAR1—nicotine dependence	0.000289	0.00565	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—CCAR1—nicotine dependence	0.000285	0.00556	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKR1B10—nicotine dependence	0.000282	0.0055	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000276	0.00539	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000273	0.00532	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGD1—nicotine dependence	0.000252	0.00491	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKR1B10—nicotine dependence	0.000222	0.00434	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—WASF2—nicotine dependence	0.000198	0.00387	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—WASF1—nicotine dependence	0.00019	0.00371	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000188	0.00367	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—OPRM1—nicotine dependence	0.000171	0.00334	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—WASF2—nicotine dependence	0.000157	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—WASF1—nicotine dependence	0.00015	0.00293	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGD1—nicotine dependence	0.000148	0.00288	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—OPRM1—nicotine dependence	0.000135	0.00264	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKR1B10—nicotine dependence	0.00013	0.00255	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DRD2—nicotine dependence	0.000124	0.00242	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DRD2—nicotine dependence	9.77e-05	0.00191	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—WASF2—nicotine dependence	9.19e-05	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—WASF1—nicotine dependence	8.81e-05	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2A7—nicotine dependence	8.81e-05	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OPRM1—nicotine dependence	7.93e-05	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2A7—nicotine dependence	7.17e-05	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DRD2—nicotine dependence	5.73e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.73e-05	0.000922	CbGpPWpGaD
